{"id":530268,"date":"2021-02-15T16:30:01","date_gmt":"2021-02-15T16:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=530268"},"modified":"2021-02-15T16:30:01","modified_gmt":"2021-02-15T16:30:01","slug":"openangle-glaucoma-market-epidemiology-pipeline-report","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/openangle-glaucoma-market-epidemiology-pipeline-report_530268.html","title":{"rendered":"Open-Angle Glaucoma Market | Epidemiology | Pipeline Report"},"content":{"rendered":"
\"Open-Angle<\/a><\/p>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s Open-angle glaucoma (OAG) Market Insights, Epidemiology, and Market Forecast\u20142030 (7MM) report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of OAG in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.<\/div>\n

Open-Angle Glaucoma is an eye disease that gradually steals vision. Typically, there no early warning signs or painful symptoms of open-angle glaucoma. It develops slowly and sometimes without noticeable sight loss for many years.<\/p>\n

Open-Angle Glaucoma Market<\/strong><\/p>\n

\"\"<\/strong><\/p>\n

 <\/p>\n

 <\/p>\n

There are three mainstays for lowering eye pressure, i.e. medication, laser, and surgery. The two types of laser treatments currently used are Selective Laser Trabeculoplasty (SLT) and Argon Laser Trabeculoplasty (ALT). Surgery for Open-Angle Glaucoma includes Cataract Surgery, Micro-Invasive Glaucoma Surgery (MIGS), Trabeculectomy, Drainage Implant Surgery, and Ciliary Body Ablation. There is an array of medications to lower the intraocular pressure in Open-Angle Glaucoma, which are divided into five major classes, i.e., Prostaglandin Analogs, Beta Blockers, Diuretics, Cholinergic Agonists (Parasympthomimetics), and Alpha Agonists. Monotherapy and combination therapy should be given for effective treatment of Open-angle glaucoma (OAG).   <\/p>\n

According to DelveInsight, the Market Size of Open-Angle Glaucoma<\/a> in the 7MM was <\/strong>USD 3,316.71 Million<\/strong> in 2017.<\/strong><\/p>\n

The current Open-Angle Glaucoma therapeutic landscape of advanced stage OAG is driven by several approved therapies, including those with generic products. As per the assessments, majority of the Open-Angle Glaucoma market share is accommodated by Prostaglandin analogs, followed by Carbonic anhydrase inhibitors while Miotics contributed the least towards the Open-Angle Glaucoma market share. <\/p>\n

Open-Angle Glaucoma Epidemiology <\/strong><\/p>\n